During the past decade, Blair Gastroenterology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Blair Gastroenterology Associates" are "Adenoma" (1 trials), "Colon Cancer" (1 trials), "Colon Diseases" (1 trials), "Colon Lesion" (1 trials) and "Colon Neoplasm" (1 trials). Many other conditions were trialed in "Blair Gastroenterology Associates" in a lesser frequency.

Most popular intervention types in "Blair Gastroenterology Associates" are "Drug" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Freenome test" (1 trials), "ISIS 14803, peginterferon alfa, ribavirin" (1 trials) and "STA-5326" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blair Gastroenterology Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Blair Gastroenterology Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Blair Gastroenterology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blair Gastroenterology Associates, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".